Article
Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis.
PloS one - 1 Jan 2013
Gleim Scott, Stitham Jeremiah, Tang Wai Ho, Li Hong, Douville Karen, Chelikani Prashen, Rade Jeffrey J, Martin Kathleen A, Hwa John
Abstract excerpt
Thromboxane and its receptor have emerged as key players in modulating vascular thrombotic events. Thus, a dysfunctional hTP genetic variant may protect against (hypoactivity) or promote (hyperactivity) vascular events, based upon its activity on platelets. After extensive in silico analysis, six hTP-α variants were selected (C(68)S, V(80)E, E(94)V, A(160)T, V(176)E, and V(217)I) for detailed biochemical studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
